Novartis’ groundbreaking CAR-T cancer therapy is one big step closer to reaching patients. A panel of outside experts convened by the FDA voted 10-0 Wednesday to recommend the approval of Novartis’ CAR-T therapy, called CTL019, for the treatment of children and young adults with advanced leukemia.read more
CureSearch for Children’s Cancer announced today the opening of the application window for funding up to $75,000 direct costs per year for up to three years (and a 10% indirect cost allowance) for the 2017 Young Investigator Award in Pediatric Oncology Drug Development.read more
By Roanne Barnes Hautapu. Our 9-year-old daughter, Quinn, finished her cancer treatment a year ago. My husband and I are excited to attend her class assembly at school. Back to some normality. Familiar ground. Our comfort zone. We stroll through the school grounds...read more
Did You Know?
What We Fund
Among adults, less than 5% of those with cancer are enrolled in clinical trials. Yet for children, more than 60% of those with cancer participate in some form of clinical trial. CureSearch supports clinical trials that show promise in making a difference for children with cancer, today.